Concord Biotech’s Initial Public Offering

IndusLaw advised BRLMs on the deal.Concord Biotech issued Equity Shares aggregating up to ?15,505.21 million (USD 186.58 million). Kotak Mahindra Capital Company Limited, Citigroup Global Markets India…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Maha Kanaan

Author: Maha Kanaan

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here